Condition
Cardiac Implantable Electronic Device Infection
Total Trials
5
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05958290Not ApplicableRecruitingPrimary
Cardiac Implantable Electronic Device Lifelong Antibiotic thErapy vs Stop and See
NCT06323668Not ApplicableRecruitingPrimary
Cardiac Implantable Electronic Device RemOval Versus Full CoUrse Medical Treatment
NCT05576194CompletedPrimary
Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection
NCT03842124Not ApplicableCompletedPrimary
Improving Safety of Lead Extraction Procedures by Traction Force Sensing
NCT01043705CompletedPrimary
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Showing all 5 trials